Harbin Pharmaceutical Group Overview
- Year Founded
-
1989
- Status
-
Public
- Employees
-
2,735
- Stock Symbol
-
600829
- Investments
-
4
- Share Price
-
$1.53
- (As of Friday Closing)
Harbin Pharmaceutical Group General Information
Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Contact Information
Website
www.hayao.comCorporate Office
- Number 7, Qunli Avenue
- Daoli District
- Harbin, Heilongjiang 150070
- China
Corporate Office
- Number 7, Qunli Avenue
- Daoli District
- Harbin, Heilongjiang 150070
- China
Harbin Pharmaceutical Group Stock Performance
As of 13-Nov-2026, Harbin Pharmaceutical Group’s stock price is $1.53. Its current market cap is $885M with 580M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.53 | $1.47 | $1.11 - $2.55 | $885M | 580M | 20.1M | $0.04 |
Harbin Pharmaceutical Group Financials Summary
As of 30-Sep-2026, Harbin Pharmaceutical Group has a trailing 12-month revenue of $1.54B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 816,863 | 912,159 | 616,266 | 654,684 |
| Revenue | 1,543,520 | 1,443,228 | 1,400,367 | 1,468,573 |
| EBITDA | 35,612 | 37,419 | 51,463 | 65,990 |
| Net Income | 23,008 | 18,611 | 29,722 | 41,296 |
| Total Assets | 1,105,534 | 1,025,466 | 981,655 | 1,047,663 |
| Total Debt | 104,749 | 104,674 | 123,306 | 143,778 |
Harbin Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Harbin Pharmaceutical Group Comparisons
Industry
Financing
Details
Harbin Pharmaceutical Group Competitors (24)
One of Harbin Pharmaceutical Group’s 24 competitors is LNK International, a Corporation company based in Hauppauge, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LNK International | Corporation | Hauppauge, NY | ||||
| China Resources Pharmaceutical Group | Corporation | Hong Kong, Hong Kong | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| OncBioMune Pharmaceuticals | Corporate Backed or Acquired | Baton Rouge, LA | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
Harbin Pharmaceutical Group Signals
Harbin Pharmaceutical Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Harbin Pharmaceutical Group Investments & Acquisitions (4)
Harbin Pharmaceutical Group’s most recent deal was a Buyout/LBO with General Nutrition Centers for . The deal was made on 07-Aug-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| General Nutrition Centers | 07-Aug-2020 | Buyout/LBO | Pharmaceuticals | ||
| Chinese Health Products (GNC/Harbin Pharmaceutical Group) | 13-Feb-2019 | Joint Venture | Other Consumer Non-Durables | ||
| General Nutrition Centers | 13-Feb-2019 | PIPE | Pharmaceuticals | ||
| Pfizer(swine vaccine business) | 31-May-2010 | Merger/Acquisition | Drug Delivery |
Harbin Pharmaceutical Group ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Harbin Pharmaceutical Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| General Nutrition Centers | Pittsburgh, PA | 1935 |
Harbin Pharmaceutical Group FAQs
-
When was Harbin Pharmaceutical Group founded?
Harbin Pharmaceutical Group was founded in 1989.
-
Where is Harbin Pharmaceutical Group headquartered?
Harbin Pharmaceutical Group is headquartered in Harbin, China.
-
What is the size of Harbin Pharmaceutical Group?
Harbin Pharmaceutical Group has 2,735 total employees.
-
What industry is Harbin Pharmaceutical Group in?
Harbin Pharmaceutical Group’s primary industry is Pharmaceuticals.
-
Is Harbin Pharmaceutical Group a private or public company?
Harbin Pharmaceutical Group is a Public company.
-
What is Harbin Pharmaceutical Group’s stock symbol?
The ticker symbol for Harbin Pharmaceutical Group is 600829.
-
What is the current stock price of Harbin Pharmaceutical Group?
As of 13-Nov-2026 the stock price of Harbin Pharmaceutical Group is $1.53.
-
What is the current market cap of Harbin Pharmaceutical Group?
The current market capitalization of Harbin Pharmaceutical Group is $885M.
-
What is Harbin Pharmaceutical Group’s current revenue?
The trailing twelve month revenue for Harbin Pharmaceutical Group is $1.54B.
-
Who are Harbin Pharmaceutical Group’s competitors?
LNK International, China Resources Pharmaceutical Group, Pfizer (Vienna), OncBioMune Pharmaceuticals, and Pfizer Pakistan are some of the 24 competitors of Harbin Pharmaceutical Group.
-
What is Harbin Pharmaceutical Group’s annual earnings per share (EPS)?
Harbin Pharmaceutical Group’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process